Familial congenital non-immune hydrops, chylothorax, and pulmonary lymphangiectasia

American Journal of Medical Genetics

Volumn 140 A, Issue 4, 2006, Pages 368-372

  Stevenson, David A ^a   Pysher, Theodore J ^a   Ward, Robert M ^a   Carey, John C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Chylothorax; Congenital pulmonary lymphangiectasia; Familial; Hydrops

Indexed keywords

VASCULOTROPIN RECEPTOR 3;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CASE REPORT; CHYLOTHORAX; COMORBIDITY; FAMILIAL DISEASE; FEMALE; FOXC2 GENE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; HYDROPS; LYMPH VESSEL; LYMPHANGIECTASIS; MALE; MILROY DISEASE; NEWBORN; NEWBORN DEATH; PLEURA EFFUSION; PRIORITY JOURNAL; RARE DISEASE; SIBLING; SURGICAL DRAINAGE; VEGFR3 GENE;

ABNORMALITIES, MULTIPLE; ADOLESCENT; CHYLOTHORAX; EDEMA; FATAL OUTCOME; FEMALE; GENES, RECESSIVE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LUNG DISEASES; LYMPHANGIECTASIS; LYMPHEDEMA; MALE; PLEURAL EFFUSION; PREGNANCY;

EID: 32444445771     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.31093     Document Type: Article

References (18)

1. Albers GM, Wood RE. 1993. Lower respiratory organs. In: Stevenson RE, Hall JG, Goodman RM. editors. Human malformations and related anomalies. New York, Oxford: Oxford University Press, p 361-362.
2. Allanson JE. 1993. Lymphatic circulation. In: Stevenson RE, Hall JG, Goodman RM, editors. Human malformations and related anomalies. New York, Oxford: Oxford University Press. p 271-287.
3. Baird AR, Nwosu CR, Crichton F, Carey FA, Lang S, Agustsson P. 1997. Isolated congenital pulmonary lymphangiectasis in a dizygotic twin pregnancy. J Obstet Gynaecol 17:492-494.
4. Bellini C, Mazzella M, Campisi C, Taddei C, Mosca F, Toma P, Villa G, Boccardo F, Sementa AR, Hennekam RC, Serra G. 2004. Multimodal imaging in the congenital pulmonary lymphagiectasia-congenital chylothorax-hydrops fetalis continuum. Lymphology 37:22-30.
5. Evans AL, Bell R, Brice G, Comeglio P, Lipede C, Jeffery S, Mortimer P, Sarfarazi M, Child AH. 2003. Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. J Med Genet 40:697-703.
6. Ferrell RE. 2002. Research perspectives in inherited lymphatic disease. Ann N Y Acad Sci 979:39-51.
7. Finegold DN, Kimak MA, Lawrence EC, Levinson KL, Cherniske EM, Pober BR, Dunlap JW, Ferrell KE. 2001. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet 10:1185-1189.
8. Gilewski MK, Statler CC, Kohut G, Toriello HV. 1996. Congenital pulmonary lymphangiectasia and other anomalies in a child: Provisionally unique syndrome? Am J Med Genet 66:438-440.
9. Huang XZ, Wu JF, Ferrando R, Lee JH, Wang YL, Farese RV Jr, Sheppard D. 2000. Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol Cell Biol 20:5208-5215.
10. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. 2000. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67:295-301.
11. Jacquemont S, Barbarot S, Bocéno M, Stalder JF, David A. 2000. Familial congenital pulmonary lymphangectasia, nonimmune hydrops fetalis, facial and lower limb lymphedema: Confirmation of Njolstad's report. Am J Med Genet 93:264-268.
12. Moerman P, Vandenberghe K, Devlieger H, Van Hole C, Fryns JP, Lauweryns JM. 1993. Congenital pulmonary lymphangiectasis with chylothorax: A heterogeneous lymphatic vessel abnormality. Am J Med Genet 47:54-58.
13. Njolstad PR, Reigstad H, Westby J, Espeland A. 1998. Familial non-immune hydrops fetalis and congenital pulmonary lymphangiectasia. Eur J Pediatr 157:498-501.
14. Noonan JA, Walters LR, Reeves JT. 1970. Congenital pulmonary lymphangiectasis. Am J Dis Child 120:314-319.
15. Saaristo A, Karkkainen MJ, Alitalo K. 2002. Insights into the molecular pathogenesis and targeted treatment of lymphedema. Ann N Y Acad Sci 979:94-110.
16. Scott-Emuakpor AB, Warren ST, Kapur S, Quiachon EB, Higgins JV. 1981. Familial occurrence of congenital pulmonary lymphangiectasia: Genetic implications. Am J Dis Child 135:532-534.
17. Traboulsi El, Al-Khayer K, Matsumoto M, Kimak MA, Crowe S, Wilson SH, Finegold DN, Ferrell RE, Meisler DM. 2002. Lymphedema-distichiasis syndrome and FOXC2 gene mutation. Am J Ophthalmol 134:592-596.
18. Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW. 2003. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 111:717-725.